238 related articles for article (PubMed ID: 16883945)
1. [Retinal changes in patients with familial adenomatous polyposis].
Cymerys E; Pecold K; Paszkowski J; Banasiewicz T; Krokowicz P
Klin Oczna; 2006; 108(1-3):70-2. PubMed ID: 16883945
[TBL] [Abstract][Full Text] [Related]
2. [Interest in ophthalmologic examination for familial adenomatous polyposis].
Collignon N; Collignon-Brach J; Galand A
Bull Soc Belge Ophtalmol; 1999; 274():11-6. PubMed ID: 10670158
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.
Lam DS; Kwok SP; Kwok AK; Liew CT; Lau JW; Pang CC
Chin Med J (Engl); 1998 Mar; 111(3):278-81. PubMed ID: 10374435
[TBL] [Abstract][Full Text] [Related]
4. [Congenital hypertrophy of retinal pigment epithelium in familial colonic polyposis. Study of a family].
Ramia Angel JM; Montero Rodríguez M; Ramírez Fe C; Sáenz Regalado D; Villeta Plaza R; Alcalde Escribano J; Morales Gutiérrez C; Abad Barahona A
Rev Esp Enferm Dig; 1993 Nov; 84(5):297-9. PubMed ID: 8305256
[TBL] [Abstract][Full Text] [Related]
5. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
Parisi ML
J Am Optom Assoc; 1995 Feb; 66(2):106-12. PubMed ID: 7714311
[TBL] [Abstract][Full Text] [Related]
6. Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis.
Polkinghorne PJ; Ritchie S; Neale K; Schoeppner G; Thomson JP; Jay BS
Eye (Lond); 1990; 4 ( Pt 1)():216-21. PubMed ID: 2157613
[TBL] [Abstract][Full Text] [Related]
7. Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis.
Baker RH; Heinemann MH; Miller HH; DeCosse JJ
Am J Med Genet; 1988 Oct; 31(2):427-35. PubMed ID: 2852900
[TBL] [Abstract][Full Text] [Related]
8. Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods.
Caspari R; Friedl W; Böker T; Augustin A; Mandl M; Jaeger K; Gallkowski K; Propping P
Z Gastroenterol; 1993 Nov; 31(11):646-52. PubMed ID: 8291275
[TBL] [Abstract][Full Text] [Related]
9. [Familial adenomatous polyposis (FAP): integration of clinical and genetic parameters in the screening of subjects at risk. A one-family example].
Chautems R; Givel JC
Swiss Surg; 1996; 2(5):196-200. PubMed ID: 8963844
[TBL] [Abstract][Full Text] [Related]
10. [Congenital hypertrophy of retinal pigment epithelium: a marker in familial adenomatous polyposis].
Szwarcberg J; Limacher JM; Fricker JP; Flament J
J Fr Ophtalmol; 1999 Apr; 22(3):364-70. PubMed ID: 10337595
[TBL] [Abstract][Full Text] [Related]
11. [Value of congenital hypertrophy of the retinal pigment epithelium as diagnostic marker in familial adenomatous polyposis].
Chagas C; Fidalgo P; Martins A; Barata A; Leitão CN; Mira FC; Ramalho PS
Acta Med Port; 1993 Jul; 6(7):303-6. PubMed ID: 8397471
[TBL] [Abstract][Full Text] [Related]
12. The presence of congenital hypertrophy of the retinal pigment epithelium in a subgroup of patients with adenomatous polyposis coli mutations.
Reck AC; Bunyan D; Eccles D; Humphry R
Eye (Lond); 1997; 11 ( Pt 3)():298-300. PubMed ID: 9373466
[TBL] [Abstract][Full Text] [Related]
13. Ocular findings in familial adenomatous polyposis.
Gelisken O; Yücel A; Güler K; Zorluoglu A
Int Ophthalmol; 1997-1998; 21(4):205-8. PubMed ID: 9700007
[TBL] [Abstract][Full Text] [Related]
14. [When is congenital hypertrophy of the retinal pigment epithelium (CHRPE) associated with the Gardner's syndrome? An overview with clinical examples].
Meyer CH; Becker R; Schmidt JC; Kroll P
Klin Monbl Augenheilkd; 2002 Sep; 219(9):644-8. PubMed ID: 12410463
[TBL] [Abstract][Full Text] [Related]
15. [Complex screening of family members at risk for familial adenomatous polyposis].
Kristóf T; Tóth T; Ujszászy L; Juhász L; Korompai K; Minik K; Papp Z
Orv Hetil; 1997 Dec; 138(50):3159-64. PubMed ID: 9446080
[TBL] [Abstract][Full Text] [Related]
16. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP).
Rossato M; Rigotti M; Grazia M; Turco AE; Bonomi L
Acta Ophthalmol Scand; 1996 Aug; 74(4):338-42. PubMed ID: 8883546
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli.
Hickey-Dwyer MU; Willoughby CE
Eye (Lond); 1993; 7 ( Pt 4)():562-4. PubMed ID: 8253239
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography findings of pigmented fundus lesions in familial adenomatous polyposis.
Tzu JH; Cavuoto KM; Villegas VM; Dubovy SR; Capo H
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(1):69-70. PubMed ID: 24266367
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.
Ruhswurm I; Zehetmayer M; Dejaco C; Wolf B; Karner-Hanusch J
Am J Ophthalmol; 1998 May; 125(5):680-6. PubMed ID: 9625552
[TBL] [Abstract][Full Text] [Related]
20. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.
Nieuwenhuis MH; De Vos Tot Nederveen Cappel W; Botma A; Nagengast FM; Kleibeuker JH; Mathus-Vliegen EM; Dekker E; Dees J; Wijnen J; Vasen HF
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):215-9. PubMed ID: 18237870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
